Pharma to get its skates on as EMA sets adaptive licensing pilot deadline
This article was originally published in SRA
Executive Summary
Drug companies wishing to take part in the European Medicines Agency's adaptive licensing pilot will need to get their skates on if they want to be considered as candidates.